Status
Conditions
Treatments
About
The aim of the current study is to compare the effect of popliteus muscle release and Kinesio taping on pain intensity, function, dynamic balance, and quadriceps muscle strength in patients with patellofemoral pain syndrome.
Full description
Patellofemoral pain syndrome has been described as one of the most perplexing and clinically challenging chronic disorders.
Symptoms usually include diffuse pain originating from the anterior aspect of the patella and commonly along the medial aspect of the knee. It therefore limits daily activities that need loading on a flexed knee. There is a high incidence, especially among runners, with patellofemoral pain syndrome accounting for 46% of running-related injuries. However, the etiology of this disorder remains vague and controversial. This is reflected in the lack of consensus on how patellofemoral pain syndrome should be treated clinically. Patellofemoral pain syndrome participants have demonstrated abnormal gait patterns with decreased stance phase knee flexion, decreased walking velocity, and decreased muscle activity of the quadriceps musculature. Restoration of normal gait kinematics may be an important component of improving function.
The soft tissue manipulation decreased knee pain and improved muscle activity. Therefore, incorporating popliteus manipulation can be effective in the treatment of anterior knee pain.
Several systematic reviews and meta-analyses of Kinesio Taping treatment in different knee or musculoskeletal problems have been published in recent years. The support taping could reduce pain as an adjunct to traditional exercise therapy in patients with patellofemoral pain syndrome.
Kinesio Taping has a significant effect on pain reduction, motor function improvement, and muscle activity change.
So, the current study will help to determine the effect of myofascial release and Kinesio Taping of the popliteus muscle on patellofemoral pain syndrome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
48 participants in 3 patient groups
Loading...
Central trial contact
Hafsa He Abdullah, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal